not used

Industry

CPC
C07K14/4701

This industry / category may be too specific. Please go to a parent level for more data

Parent Industries

CCHEMISTRY METALLURGY C07Organic chemistry C07KPEPTIDES C07K14/00Peptides having more than 20 amino acids Gastrins Somatostatins Melanotropins Derivatives thereof

Current Industry

C07K14/4701not used

Industries

Please log in for detailed analytics

Patents Grantslast 30 patents

Information Patent Grant
Erythrocyte-binding therapeutics
- Patent number 11,884,721
- Issue date Jan 30, 2024
- Ecole Polytechnique Federale de Lausanne (EPFL)
- Jeffrey A. Hubbell
- B82 - NANO-TECHNOLOGY
Information Patent Grant
Pharmaceutical use of FAM19A5 involved in regulating gliogenesis
- Patent number 11,739,141
- Issue date Aug 29, 2023
- Neuracle Science Co., Ltd.
- Jae Young Seong
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Cell-based assay for determining mTOR activity
- Patent number 11,485,763
- Issue date Nov 1, 2022
- Medical Diagnostics Laboratories, LLC
- Elisa A Waxman
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Erythrocyte-binding therapeutics
- Patent number 10,919,963
- Issue date Feb 16, 2021
- Ecole Polytechnique Federale de Lausanne (EPFL)
- Jeffrey A. Hubbell
- B82 - NANO-TECHNOLOGY
Information Patent Grant
Pharmaceutical use of FAM19A5 involved in regulating gliogenesis
- Patent number 10,640,557
- Issue date May 5, 2020
- Neuracle Sceince, Inc.
- Jae Young Seong
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Erythrocyte-binding therapeutics
- Patent number 10,392,437
- Issue date Aug 27, 2019
- Ecole Polytechnique Federale de Lausanne (EPFL)
- Jeffrey A. Hubbell
- B82 - NANO-TECHNOLOGY
Information Patent Grant
Solid phase peptide synthesis
- Patent number 10,125,163
- Issue date Nov 13, 2018
- CEM Corporation
- Jonathan M. Collins
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Nuclear factor-erythroid 2 related factor 2 (NRF2) biosensors and m...
- Patent number 10,054,583
- Issue date Aug 21, 2018
- Temple University - of the Commonwealth System of Higher Education
- Oscar M. Perez-Leal
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Pharmaceutical use of FAM19A5 involved in regulating gliogenesis
- Patent number 9,579,398
- Issue date Feb 28, 2017
- Neuracle Science Co., Ltd.
- Jae Young Seong
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Erythrocyte-binding therapeutics
- Patent number 9,518,087
- Issue date Dec 13, 2016
- Ecole Polytechnique Federale de Lausanne (EPFL)
- Jeffrey A. Hubbell
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Vesicle trafficking proteins
- Patent number 7,947,804
- Issue date May 24, 2011
- Incyte Corporation
- Olga Bandman
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
In vivo chemosensitivity screen for human tumors
- Patent number 6,620,403
- Issue date Sep 16, 2003
- Roman Perez-Soler
- A01 - AGRICULTURE FORESTRY ANIMAL HUSBANDRY HUNTING TRAPPING FISHING
Information Patent Grant
Response element
- Patent number 6,472,515
- Issue date Oct 29, 2002
- Biovitrum AB
- Isabel Climent-Johansson
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Vesicle trafficking proteins
- Patent number 6,071,703
- Issue date Jun 6, 2000
- INCYTE Pharmaceuticals, Inc.
- Olga Bandman
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Vesicle trafficking proteins
- Patent number 5,989,859
- Issue date Nov 23, 1999
- INCYTE Pharmaceuticals, Inc.
- Olga Bandman
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Patents Applicationslast 30 patents

Information Patent Application
ERYTHROCYTE-BINDING THERAPEUTICS
- Publication number 20240279330
- Publication date Aug 22, 2024
- ECOLE POLYTECHNIQUE FEDERALE DE LAUSANNE (EPFL)
- Jeffrey A. Hubbell
- B82 - NANO-TECHNOLOGY
Information Patent Application
PHARMACEUTICAL USE OF FAM19A5 INVOLVED IN REGULATING GLIOGENESIS
- Publication number 20240166735
- Publication date May 23, 2024
- NEURACLE SCIENCE CO., LTD.
- Jae Young SEONG
- C07 - ORGANIC CHEMISTRY
Information Patent Application
ERYTHROCYTE-BINDING THERAPEUTICS
- Publication number 20210238277
- Publication date Aug 5, 2021
- ECOLE POLYTECHNIQUE FEDERALE DE LAUSANNE (EPFL)
- Jeffrey A. Hubbell
- B82 - NANO-TECHNOLOGY
Information Patent Application
Pharmaceutical Use of FAM19A5 Involved in Regulating Gliogenesis
- Publication number 20200270337
- Publication date Aug 27, 2020
- NEURACLE SCIENCE CO., LTD.
- Jae Young SEONG
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ERYTHROCYTE-BINDING THERAPEUTICS
- Publication number 20190382479
- Publication date Dec 19, 2019
- ECOLE POLYTECHNIQUE FEDERALE DE LAUSANNE (EPFL)
- Jeffrey A. Hubbell
- C07 - ORGANIC CHEMISTRY
Information Patent Application
NOVEL CELL-BASED ASSAY FOR DETERMINING mTOR ACTIVITY
- Publication number 20190263875
- Publication date Aug 29, 2019
- MEDICAL DIAGNOSTIC LABORATORIES, LLC
- Elisa A Waxman
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
SOLID PHASE PEPTIDE SYNTHESIS
- Publication number 20190194246
- Publication date Jun 27, 2019
- CEM Corporation
- JONATHAN M. COLLINS
- C07 - ORGANIC CHEMISTRY
Information Patent Application
SOLID PHASE PEPTIDE SYNTHESIS
- Publication number 20170226152
- Publication date Aug 10, 2017
- CEM Corporation
- JONATHAN M. COLLINS
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
NUCLEAR FACTOR-ERYTHROID 2 RELATED FACTOR 2 (NRF2) BIOSENSORS AND M...
- Publication number 20160146785
- Publication date May 26, 2016
- Temple University - Of The Commonwealth System of Higher Education
- Oscar M. PEREZ-LEAL
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
Methods of Treating Glucose Metabolism Disorders
- Publication number 20140154271
- Publication date Jun 5, 2014
- NGM Biopharmaceuticals, Inc.
- Maria Deato
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ERYTHROCYTE-BINDING THERAPEUTICS
- Publication number 20120039989
- Publication date Feb 16, 2012
- Jeffrey A. Hubbell
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Novel human cancer/testis antigen and gene thereof
- Publication number 20040029197
- Publication date Feb 12, 2004
- Masato Takimoto
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Methods for increasing mRNA half-life in eukaryotic cells
- Publication number 20030199092
- Publication date Oct 23, 2003
- The Regents of the University of California.
- David L. Meyer
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Novel response element
- Publication number 20030143583
- Publication date Jul 31, 2003
- Biovitrum AB, a Swedish corporation
- Isabel Climent-Johansson
- C07 - ORGANIC CHEMISTRY
Information Patent Application
In vivo chemosensitivity screen for human tumors
- Publication number 20020031473
- Publication date Mar 14, 2002
- Roman Perez-Soler
- C07 - ORGANIC CHEMISTRY

Industry

Parent Industries

Current Industry

Patents Grantslast 30 patents

Erythrocyte-binding therapeutics

Pharmaceutical use of FAM19A5 involved in regulating gliogenesis

Cell-based assay for determining mTOR activity

Erythrocyte-binding therapeutics

Pharmaceutical use of FAM19A5 involved in regulating gliogenesis

Erythrocyte-binding therapeutics

Solid phase peptide synthesis

Nuclear factor-erythroid 2 related factor 2 (NRF2) biosensors and m...

Pharmaceutical use of FAM19A5 involved in regulating gliogenesis

Erythrocyte-binding therapeutics

Vesicle trafficking proteins

In vivo chemosensitivity screen for human tumors

Response element

Vesicle trafficking proteins

Vesicle trafficking proteins

Patents Applicationslast 30 patents

ERYTHROCYTE-BINDING THERAPEUTICS

PHARMACEUTICAL USE OF FAM19A5 INVOLVED IN REGULATING GLIOGENESIS

ERYTHROCYTE-BINDING THERAPEUTICS

Pharmaceutical Use of FAM19A5 Involved in Regulating Gliogenesis

ERYTHROCYTE-BINDING THERAPEUTICS

NOVEL CELL-BASED ASSAY FOR DETERMINING mTOR ACTIVITY

SOLID PHASE PEPTIDE SYNTHESIS

SOLID PHASE PEPTIDE SYNTHESIS

NUCLEAR FACTOR-ERYTHROID 2 RELATED FACTOR 2 (NRF2) BIOSENSORS AND M...

Methods of Treating Glucose Metabolism Disorders

ERYTHROCYTE-BINDING THERAPEUTICS

Novel human cancer/testis antigen and gene thereof

Methods for increasing mRNA half-life in eukaryotic cells

Novel response element

In vivo chemosensitivity screen for human tumors